Summary
Dr. Thomas Karikari, Assistant Professor, University of Pittsburgh, and a a leading researcher in the field of blood-based biomarkers for Alzheimer’s disease, is redefining Alzheimer’s biomarker research with the SPEAR UltraDetect™ pTau 217 Assay.
Using the using the SPEAR UltraDetect pTau 217 Assay across two cohorts, he shows this assay consistently outperformed other assays in accuracy, sensitivity, and precision, even when working with archived samples that have undergone multiple freeze-thaw cycles. This breakthrough in blood-based biomarker research has the potential to transform Alzheimer’s research by providing a reliable, scalable, and accurate testing method for the disease.
Learn more about SPEAR UltraDetect Assays distributed by Bio-Techne.
Request Literature
To access this literature content please fill out the form below.